---
title: Impact of an irreversible β-galactosylceramidase inhibitor on the lipid profile
  of zebrafish embryos
date: '2024-04-10'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38596316/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240410180518&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Krabbe disease is a sphingolipidosis characterized by the genetic deficiency
  of the acid hydrolase β-galactosylceramidase (GALC). Most of the studies concerning
  the biological role of GALC performed on Krabbe patients and Galc-deficient twitcher
  mice (an authentic animal model of the disease) indicate that the pathogenesis of
  this disorder is the consequence of the accumulation of the neurotoxic GALC substrate
  β-galactosylsphingosine (psychosine), ignoring the possibility that this enzyme
  ...
disable_comments: true
---
Krabbe disease is a sphingolipidosis characterized by the genetic deficiency of the acid hydrolase β-galactosylceramidase (GALC). Most of the studies concerning the biological role of GALC performed on Krabbe patients and Galc-deficient twitcher mice (an authentic animal model of the disease) indicate that the pathogenesis of this disorder is the consequence of the accumulation of the neurotoxic GALC substrate β-galactosylsphingosine (psychosine), ignoring the possibility that this enzyme ...